[Federal Register Volume 62, Number 97 (Tuesday, May 20, 1997)]
[Notices]
[Pages 27612-27613]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13142]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[INFO-97-11]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques for other 
forms of information technology. Send comments to Wilma Johnson, CDC 
Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 
30333. Written comments should be received within 60 days of this 
notice.

Proposed Projects

    1. National Inventory of Clinical Laboratory Testing Services 
(NICLTS)--New--This is a new data collection. CDC proposes to gather 
data through the use of a mail/telephone-assisted survey of a 
statistical sample of waived and provider performance microscopy (PPM) 
certified laboratories. The use of a mail/telephone survey instrument 
will be a cost-effective approach for performing the inventory of 
clinical laboratory testing services by analytes, test systems, 
specimen types and test volume in laboratories with limited menus such 
as waived and PPM facilities.
    The data collected in this study will provide the government, 
policy makers, practitioners and researchers with national estimates of 
analytes, test systems, and test volumes being performed in each of the 
ten defined regions in the United States in waived and PPM 
laboratories.
    This baseline survey will be analyzed and used by CDC in: (1) 
responding to questions concerning the impact of both regulatory and 
non-regulatory changes in the delivery of clinical laboratory medicine 
to Congress, DHHS, and the public; (2) allowing the government to track 
changes in public access to clinical laboratory testing and to 
determine what and where tests are available; (3) predicting the impact 
of proposed regulatory changes on laboratory services, the government 
can respond to requests for information from a position of more 
complete knowledge and understanding than the partial information 
currently available; and (4) monitoring the changes in laboratory

[[Page 27613]]

testing as our health care delivery systems moves toward managed care. 
The cost to the respondents is $0.

------------------------------------------------------------------------
                                                   No. of               
                                      No. of     responses/     Total   
           Respondents             respondents   respondent   burden (in
                                                 (in hrs.)      hrs.)   
------------------------------------------------------------------------
PPM Certified Laboratories.......        1,178            1            1
    Total........................  ...........  ...........        1,178
------------------------------------------------------------------------

    Dated: May 14, 1997.
Wilma G. Johnson,
Acting Associate Director for Policy Planning And Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 97-13142 Filed 5-19-97; 8:45 am]
BILLING CODE 4163-18-P